Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH antagonist versus long GnRH agonist protocol in non-obese women with polycystic ovary syndrome undergoing IVF/ICSI
ACTRN12607000636459Phase 4Completed
- Sponsor
- Polish Committee of Scientific Research
- Start
- Feb 2004
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cetrorelix and triptorelin in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Polish Committee of Scientific Research. Primary endpoints: Delivery per attempt, Clinical pregnancy per attempt and 1 more. Started Feb 2004; status: completed.
02
Drugs
cetrorelixtriptorelin
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on ACTRN12607000636459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000636459.